DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) SHH

16.55

-0.17(-1.02%)

Updated at September 30 11:29AM

Currency In CNY

Valuation

Market Cap17.01B
Enterprise Value17.11B
P/E Ratio18.03
PEG Ratio2.58
Price/Sales Ratio0.7
Price/Book Ratio2.6
Enterprise/Revenue0.66
Enterprise/EBITDA11.27

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.04
Operating Margin0.06

Management Effectiveness

Return On Assets0.04
Return On Equity0.15

Income Statement

Revenue26.5B
Revenue/Share23.17
Gross Profit9.1B
EBITDA3.03B
Net Income914.75M
Diluted EPS0.81

Balance Sheet

Total Cash5.94B
Total Cash/Share5.16
Total Debt4.82B
Total Debt/Equity0.66
Current Ratio0.97
Book Value Per Share7.49

Price History

52-Week Change1.6
52-Week High19
52-Week Low13.5
Moving Average 50 Days17.26
Moving Average 200 Days16.36

Statistics

Average Volume6.48M
Shares Outstanding1.13B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield3.75
Payout Ratio0.7
Last Split Factor6:5
Last Split DateJune 09, 2023